Author response for "Dapagliflozin vs Non‐SGLT‐2i Treatment is Associated with Lower Hospital Care Costs in Type 2 Diabetes Patients Similar to the DECLARE‐TIMI 58 Participants: A Nationwide Observational Study"

Author(s):  
Anna Norhammar ◽  
Johan Bodegard ◽  
Thomas Nyström ◽  
Marcus Thuresson ◽  
Klas Rikner ◽  
...  
Sign in / Sign up

Export Citation Format

Share Document